NOVEL TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASES

    公开(公告)号:US20190054063A1

    公开(公告)日:2019-02-21

    申请号:US16166357

    申请日:2018-10-22

    CPC classification number: A61K31/355 A61K31/22 A61P1/16

    Abstract: The present invention relates to the use of mixtures of vitamin E and polyunsaturated fatty acids (PUFAs) as agents for the prevention, control and/or treatment of conditions associated with excessive fat accumulation in the liver which is not caused by alcohol abuse. This includes prevention, control and/or treatment of non-alcoholic steatosis in the liver—known as non-alcoholic fatty liver disease (NAFLD)—and/or non-alcoholic steatohepatitis (NASH) in a subject in need thereof. In particular, the present invention relates to the use of such compounds comprising vitamin E acetate and DHA EE as active ingredients in the manufacture of medicaments for the prevention, control and/or treatment of conditions related to NAFLD.

    PROCESS FOR THE PRODUCTION OF DIGLYCERIDES

    公开(公告)号:US20210238499A1

    公开(公告)日:2021-08-05

    申请号:US16972153

    申请日:2019-06-04

    Abstract: A method for producing diglycerides is provided. The method includes combining (i) an oil comprising at least one polyunsaturated fatty acid in the form of ethyl esters, free fatty acids, and/or combinations thereof, (ii) lipase, and (iii) glycerol in water to produce diglycerides with a high level of purity. Highly pure diglycerides obtained according to the method are also provided.

Patent Agency Ranking